83 related articles for article (PubMed ID: 17291149)
1. Complement component C5a predicts restenosis after superficial femoral artery balloon angioplasty.
Speidl WS; Exner M; Amighi J; Mlekusch W; Sabeti S; Kastl SP; Zorn G; Maurer G; Wagner O; Huber K; Minar E; Wojta J; Schillinger M
J Endovasc Ther; 2007 Feb; 14(1):62-9. PubMed ID: 17291149
[TBL] [Abstract][Full Text] [Related]
2. What is lining your full metal jacket?
Gray BH
Catheter Cardiovasc Interv; 2011 Jun; 77(7):1063-4. PubMed ID: 21598359
[No Abstract] [Full Text] [Related]
3. Comments regarding 'Predictive risk factors for restenosis after remote superficial femoral artery endarterectomy'.
Schneider JR
Eur J Vasc Endovasc Surg; 2010 May; 39(5):604-5. PubMed ID: 20346710
[No Abstract] [Full Text] [Related]
4. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: medium-term results of a randomized controlled trial (the REVAS trial).
Gisbertz SS; Tutein Nolthenius RP; de Borst GJ; van der Laan L; Overtoom TT; Moll FL; de Vries JP
Ann Vasc Surg; 2010 Nov; 24(8):1015-23. PubMed ID: 21035693
[TBL] [Abstract][Full Text] [Related]
5. Initial results of concomitant cryoplasty after remote endarterectomy of the superficial femoral artery: a feasibility study (cryoplasty following remote endarterectomy).
Gisbertz SS; de Borst GJ; Overtoom TT; Moll FL; de Vries JP
Vasc Endovascular Surg; 2010 Jan; 44(1):20-4. PubMed ID: 19828580
[TBL] [Abstract][Full Text] [Related]
6. Initial experience with directed laser atherectomy using the CLiRpath photoablation atherectomy system and bias sheath in superficial femoral artery lesions.
Rastan A; Sixt S; Schwarzwälder U; Kerker W; Bürgelin K; Frank U; Noory E; Gremmelmeier D; Branzan D; Hauswald K; Brantner R; Schwarz T; Zeller T
J Endovasc Ther; 2007 Jun; 14(3):365-73. PubMed ID: 17723018
[TBL] [Abstract][Full Text] [Related]
7. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
[TBL] [Abstract][Full Text] [Related]
8. eComment: Femorocrural bypass surgery and intimal hyperplasia.
Hudorovic N
Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):194. PubMed ID: 19628537
[No Abstract] [Full Text] [Related]
9. Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions.
Hillegass WB
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1096. PubMed ID: 19953522
[No Abstract] [Full Text] [Related]
10. Invited commentary.
Rasmussen TE
J Vasc Surg; 2009 Sep; 50(3):548. PubMed ID: 19700092
[No Abstract] [Full Text] [Related]
11. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery.
Laxdal E; Eide GE; Wirsching J; Jenssen GL; Jonung T; Pedersen G; Amundsen SR; Dregelid E; Aune S
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):410-7. PubMed ID: 15350565
[TBL] [Abstract][Full Text] [Related]
12. Predictive risk factors for restenosis after remote superficial femoral artery endarterectomy.
Derksen WJ; Gisbertz SS; Hellings WE; Vink A; de Kleijn DP; de Vries JP; Moll FL; Pasterkamp G
Eur J Vasc Endovasc Surg; 2010 May; 39(5):597-603. PubMed ID: 20167515
[TBL] [Abstract][Full Text] [Related]
13. Functional outcome of hypogastric revascularisation for prevention of buttock claudication in patients with peripheral artery occlusive disease.
Paumier A; Abraham P; Mahé G; Maugin E; Enon B; Leftheriotis G; Picquet J
Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):323-9. PubMed ID: 19910224
[TBL] [Abstract][Full Text] [Related]
14. Long-term results with the Palmaz stent in the superficial femoral artery.
Bergeron P; Pinot JJ; Poyen V; Benichou H; Khanoyan P; Rudondy P; Wang Y; Chiarandini S; el Hussein R; Rieu R
J Endovasc Surg; 1995 May; 2(2):161-7. PubMed ID: 9234129
[TBL] [Abstract][Full Text] [Related]
15. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
Gallino A; Do DD; Alerci M; Baumgartner I; Cozzi L; Segatto JM; Bernier J; Tutta P; Kellner F; Triller J; Schneider E; Amann-Vesti B; Studer G; Jäger K; Aschwanden M; Canevascini R; Jacob AL; Kann R; Greiner R; Mahler F
J Endovasc Ther; 2004 Dec; 11(6):595-604. PubMed ID: 15615549
[TBL] [Abstract][Full Text] [Related]
16. Regarding: Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?
Teebken OE; Bauermeister G; Pichlmaier AM
Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):118. PubMed ID: 18440251
[No Abstract] [Full Text] [Related]
17. Early results of retrograde transpopliteal angioplasty of iliofemoral lesions.
Saha S; Gibson M; Magee TR; Galland RB; Torrie EP
Cardiovasc Intervent Radiol; 2001; 24(6):378-82. PubMed ID: 11907743
[TBL] [Abstract][Full Text] [Related]
18. Regarding "Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions".
Meerwaldt R; Blomme A; Fritschy W; Zeebregts CJ
J Vasc Surg; 2008 Sep; 48(3):774; author reply 774-5. PubMed ID: 18727960
[No Abstract] [Full Text] [Related]
19. Remote endarterectomy: first choice in surgical treatment of long segmental SFA occlusive disease?
Smeets L; Ho GH; Hagenaars T; van den Berg JC; Teijink JA; Moll FL
Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):583-9. PubMed ID: 12787704
[TBL] [Abstract][Full Text] [Related]
20. Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients.
Wilson SE
Ann Vasc Surg; 2010 May; 24(4):498-502. PubMed ID: 20036508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
